Navigation Links
Concord Medical Reports Fourth Quarter and Full Year 2012 Financial Results
Date:3/20/2013

on)(a), a 95.1% increase from the fourth quarter of 2011.

Cost of revenue was RMB129.6 million ($20.8 million), as compared to RMB44.8 million for the fourth quarter of 2011. The increase reflected the consolidation of the financial results of Chang'an Hospital.  Total Cost of revenue is composed of:

  • Cost of revenue of the Network Business of RMB38.0 million ($6.1 million), compared to RMB44.8 million ($7.1 million) in the fourth quarter of 2011;
  • Cost of revenue of the Hospital business of RMB91.6 million ($14.7 million).
  • Gross profit was RMB93.1 million ($14.9 million), representing a 34.2% increase from the fourth quarter of 2011. The gross profit margin for the fourth quarter of 2012 was 41.8%. Gross profit for the fourth quarter of 2012 consisted of:

  • gross profit from the network business in the amount of RMB79.1 million ($12.1 million), representing a gross profit margin of 67.6%; and
  • gross profit from the hospital business in the amount of RMB13.9 million ($2.2 million), representing a gross profit margin of 13.2%.
  • Operating expenses were RMB35.9 million ($5.8 million) for the fourth quarter of 2012..

    Operating income was RMB57.2 million ($9.2 million) for the fourth quarter of 2012.

    Income tax expense was RMB22.7 million ($3.6 million) for the fourth quarter of 2012.. The effective tax rate for the fourth quarter of 2012 was 40.3%, partially due to Chang'an Hospital's accrued tax expenses in the fourth quarter.

    Net income was RMB33.6 million ($5.4 million) for the fourth quarter of 2012, compared to net loss of RMB310.0 million ($49.3 million) in the fourth quarter of 2011. The net profit margin in the fourth quarter of 2012 was 15.1%.

    Basic and diluted earnings per American depositary share ("ADS") for the fourth quarter of 2012 were both RMB0.68 ($0.11). Each ADS represents three ordinary shares.

    Adjusted EBITDA(c) (non-GAAP) was RMB1
    '/>"/>

    SOURCE Concord Medical Services Holdings Limited
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Concord Medical to Report Fourth Quarter and Full Year 2012 Financial Results on March 20, 2013
    2. DDS Lab Announces Strategic Alliance with United Concordia
    3. Concord Medical Acquires Ownership Interest in MD Anderson Cancer Center Proton Therapy Center
    4. Concord Medical to Hold Annual General Meeting on December 22, 2012
    5. Concord Medical Reports Third Quarter 2012 Financial Results
    6. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
    7. Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012
    8. Concord Medical Responds to Unusual Market Activity in its Stock
    9. Concord Medical Reports Second Quarter 2012 Financial Results
    10. Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
    11. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/22/2014)... 22, 2014 Research and Markets ... Market by Equipment, by Reagent, by Application - Global ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals ... is one of the most important and widely used ... application segment of the cell culture market in 2013. ...
    (Date:7/22/2014)... Mass. , July 22, 2014  Decision ... audited multiple sclerosis (MS) patients currently treated ... Tecfidera have ever experienced flushing and/or gastrointestinal ... Tecfidera-treated patients are currently experiencing these side ... the effective medical management of such events. ...
    (Date:7/22/2014)... 2014 The number of people overdosing from ... day. Twenty-three percent of the workforce has misused prescription ... and Health, making opioid use a serious threat to ... at the correct dosage with a valid prescription, subtle ... National Safety Council released a guide for ...
    Breaking Medicine Technology:Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 35 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3
    ... Hospital today announced that revolutionary three-dimensional mammography imaging ... patient appointments at the Evergreen Breast Center, which ... Seattle area to offer the breakthrough screening and ... three-dimensional (3-D) digital imaging to create a complete ...
    ... Prescription drug spending growth slowed from an estimated ... according to new data released today by the Centers ... in Health Affairs. Researchers credit the slowdown in spending ... shifting medication use toward lower cost generic drugs. ...
    Cached Medicine Technology:Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 2Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology 3PCMA: Study Credits PBM Tools with Reducing Prescription Drug Spending Growth 2
    (Date:7/22/2014)... American Society of Hematology (ASH) will honor Michael DeBaun, ... Robert P. Hebbel, MD, of the University of Minnesota ... Prize for their significant research advances in the area ... named for the late Ernest Beutler, MD, a past ... years, is a two-part lectureship that recognizes major translational ...
    (Date:7/22/2014)... director of research at the University of Utah,s John ... International Society of Eye Research (ISER) as the recipient ... Kayser International Award in Retina Research., The award recognizes ... a significant contribution to the understanding of vitreoretinal diseases ... at the ISER Biennial Meeting in San Francisco, where ...
    (Date:7/22/2014)... (PRWEB) July 22, 2014 Legislation ... Seniors Access to Local Pharmacies Act of 2014”) ... Part D would undermine the availability of lower ... by $21 billion over the next 10 years, ... released by the Pharmaceutical Care Management Association (PCMA). ...
    (Date:7/22/2014)... WASHINGTON -- Autoimmune disorders may share certain pathogenic mechanisms ... Washington University (GW) researcher Linda Kusner, Ph.D. , ... , This paradigm shifting work shows that the very ... are also expressed in cells that produce autoimmune diseases. ... of Neurology at the GW School of Medicine and ...
    (Date:7/22/2014)... The Beryl Institute announces its fifth annual Patient ... These offerings reinforce the Institute’s commitment to support the ... the need for rigorous research to understand and address ... are intended to encourage and support research into ... the patient experience before, during and after care (e.g., ...
    Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:New research finds pathogenic connection between autoimmune disorders and cancer 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3
    ... fluid in the middle ear, a condition called otitis media ... by antihistamines and decongestants, a new review of studies has ... in alleviating symptoms or avoiding complications of OME and expose ... ,"This review finds no benefit for any of the ...
    ... Virginia University professor and two alumni have tracked the ... the eye and often leads to blindness and death.// ... treatment for those who suffer from it. ,Joginder ... doctoral students Jason White ('02) and Alison Director-Myska ('96) ...
    ... Federal government of Australia came under the glaring critics ... its allocation of funds for various health promotion programs.// ... at the current government for lapses pertaining to health ... from rural medical facilities pharmaceuticals and after hour care ...
    ... the gut has been found to be an effective ... researchers at Cedars-Sinai Medical Center. ,The study ... the Annals of Internal Medicine It is the ... end of the course of treatment has ended. This ...
    ... reports that the board of the Central Gippsland Health Service ... ,Peter Goss and Jo McCubbin had resigned from the Sale ... such an action because of threats to services. However they ... place. ,In an open letter to the hospital board, ...
    ... Cancer’s exploits are titillated by personality traits, contemplates a ... rodents//. The idea that personality types may increase the ... ,Researchers at the University of Chicago ... point for cancer as compared to the rats that ...
    Cached Medicine News:Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 2Health News:Allergy Drugs More Harmful Than Helpful for Chronic Ear Inflammation 3Health News:Team Tracks Genetic Origins of Eye Cancer 2Health News:Federal government blamed for allocating meager portion to health sector:ALP 2Health News:IBS Sufferers Benefited by Non-Absorbable Antibiotics 2
    ... The BacT/Alert 3D Signature is ... microbial detection system that integrates blood, ... It is a powerful microbiology workstation ... for higher volume identification and where ...
    ... Vitek is a completely automated instrument that ... 2 - 6 hour same day turnaround), ... control module. It is used for bacterial ... urine screening and has a complete data ...
    IDS Rapid One, a microbial identification system....
    The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
    Medicine Products: